• Start
  • Cancer
  • Technology
    • Technology
    • Human Scaffolds
    • 3D Synthetic Scaffolds
  • Products & Services
  • Pipeline
  • News
  • Publications
  • Partners & Customers
  • About
Curing cancer by generating precision medicine Curing cancer by generating precision medicine Curing cancer by generating precision medicine Curing cancer by generating precision medicine
  • Start
  • Cancer
  • Technology
    • Technology
    • Human Scaffolds
    • 3D Synthetic Scaffolds
  • Products & Services
  • Pipeline
  • News
  • Publications
  • Partners & Customers
  • About

Archives

Author Archive for: "Admin"
Home » Archives for Admin
0
By Admin
In
Posted March 8, 2019

Pipeline

READ MORE
Human Scaffolds
0
By Admin
In
Posted February 27, 2019

Human Scaffolds

READ MORE
Publications
0
By Admin
In
Posted February 11, 2019

Publications

READ MORE
About
0
By Admin
In
Posted February 11, 2019

About

READ MORE
0
By Admin
In
Posted February 11, 2019

News

READ MORE
Partners & Customers
0
By Admin
In
Posted February 11, 2019

Partners & Customers

READ MORE
Products & Services
0
By Admin
In
Posted February 11, 2019

Products & Services

READ MORE
3D Synthetic Scaffolds
0
By Admin
In
Posted February 11, 2019

3D Synthetic Scaffolds

READ MORE
Technology
0
By Admin
In
Posted February 11, 2019

Technology

READ MORE
Cancer
0
By Admin
In
Posted February 11, 2019

Cancer

READ MORE
1 2
page 1 of 2
Recent Posts
  • Business Developer
    Business Developer
    May 1, 2024
  • Iscaffpharma’s first patent issued by the United States Patent and Trademark Office
    Iscaffpharma’s first patent issued by the United States Patent and Trademark Office
    January 26, 2024
  • SLAS honors Per Setterberg as fellow member
    SLAS honors Per Setterberg as fellow member
    October 19, 2023
Recent Publications
  • 17. Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells
    17. Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells
    December 16, 2024
  • 16. Deciphering the role of FUS::DDIT3 expression and tumor microenvironment in myxoid liposarcoma development
    16. Deciphering the role of FUS::DDIT3 expression and tumor microenvironment in myxoid liposarcoma development
    April 26, 2024
  • 15. Proteomics of cell-free breast cancer scaffolds identify clinically relevant imprinted proteins and cancer-progressing properties
    15. Proteomics of cell-free breast cancer scaffolds identify clinically relevant imprinted proteins and cancer-progressing properties
    April 4, 2024
Contact us
  • Org nr: 559120-9753
  • Iscaff Pharma AB
    Erik Dahlbergsgatan 11A
    411 26 Gothenburg
    Sweden
  • contact@iscaffpharma.com
Copyright All Rights Reserved © 2023
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt